![Steven Butcher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Butcher
Keine laufenden Positionen mehr
Profil
Steven Butcher held several positions in various firms throughout his career.
He was the Director of Target Discovery at Pharmacia & Upjohn, Inc. and the Vice President of Science at Gemini Genomics Plc.
He also served as the Chief Scientific Officer at Synaptics, Inc. and Noapab Holdings A. Additionally, he was the Operational Partner at Advent Venture Partners LLP and the Chief Operating Officer & VP-Corporate Development at Topotarget A and CoCo Therapeutics Ltd. Dr. Butcher earned a doctorate degree from The University of Southampton.
Ehemalige bekannte Positionen von Steven Butcher
| Unternehmen | Position | Ende |
|---|---|---|
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Private Equity Investor | 01.03.2019 |
Noapab Holdings A/S
 Noapab Holdings A/S Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and diagnostics products | Technik-/Wissenschafts-/F&E-Leiter | 03.04.2009 |
| SYNAPTICS INCORPORATED | Corporate Officer/Principal | 01.06.2003 |
| TOPOTARGET A/S | Geschäftsführer | - |
CoCo Therapeutics Ltd.
 CoCo Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops novel treatment for Alzheimer's disease | Geschäftsführer | - |
Ausbildung von Steven Butcher
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
16
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Pharmacia & Upjohn, Inc.
 Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Health Technology |
Gemini Genomics Plc
 Gemini Genomics Plc Miscellaneous Commercial ServicesCommercial Services Provides clinical genomics services | Commercial Services |
Synaptics, Inc.
 Synaptics, Inc. SemiconductorsElectronic Technology Develops and supplies custom-designed human interface semiconductor product solutions | Electronic Technology |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Finance |
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceuticals | Health Technology |
Noapab Holdings A/S
Noapab Holdings A/S Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and diagnostics products | Commercial Services |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CoCo Therapeutics Ltd.
CoCo Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops novel treatment for Alzheimer's disease | Health Technology |
